当前位置:首页 - 行情中心 - 卫宁健康(300253) - 财务分析 - 利润表

卫宁健康

(300253)

  

流通市值:126.49亿  总市值:146.81亿
流通股本:18.60亿   总股本:21.59亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入3,163,424,802.811,900,957,792.661,191,843,074.22449,172,857.1
营业收入3,163,424,802.811,900,957,792.661,191,843,074.22449,172,857.1
二、营业总成本2,808,746,305.491,844,538,774.811,264,007,416.22585,423,433.04
营业成本1,739,817,519.411,099,594,936.1707,073,544.42303,527,745.09
税金及附加29,649,081.2517,647,552.8510,619,099.53,394,791.61
销售费用459,498,652.9325,886,259.17244,811,581.34119,234,998.49
管理费用195,398,788.09140,645,599.74106,084,240.8651,846,167.62
研发费用333,302,222.75222,635,227.91170,270,243.9594,566,268.35
财务费用51,080,041.0938,129,199.0425,148,706.1512,853,461.88
其中:利息费用64,051,540.7347,602,278.2231,592,749.1515,655,833.3
其中:利息收入13,590,811.5810,160,884.166,803,976.813,035,595.34
加:公允价值变动收益-50,464,459.13-803,552.33-1,323,579.911,986,991.16
加:投资收益29,498,207.3819,678,480.0732,785,472.29-14,338,894.76
资产处置收益-425,833.8329,225.3628,135.741,249.87
资产减值损失(新)-136,734,803.21-101,288,334.01-81,870,945.121,562,812.42
信用减值损失(新)-7,870,229.68,735,376.686,912,674.321,936,302.3
其他收益152,749,631.1188,569,095.8362,221,774.537,028,973.86
营业利润平衡项目0000
四、营业利润341,431,010.0471,339,309.45-53,410,810.18-108,073,141.09
加:营业外收入233,232.7541,145.384,080.791,244.05
减:营业外支出917,040.02860,593.88409,641.5326,624.77
利润总额平衡项目0000
五、利润总额340,747,202.7770,519,860.95-53,816,370.92-108,098,521.81
减:所得税费用23,131,711.85-40,254,650.26-37,212,511.77-17,894,412.55
六、净利润317,615,490.92110,774,511.21-16,603,859.15-90,204,109.26
持续经营净利润317,615,490.92110,774,511.21-16,603,859.15-90,204,109.26
归属于母公司股东的净利润357,959,124.85152,336,082.2416,591,597.98-63,534,739.9
少数股东损益-40,343,633.93-41,561,571.03-33,195,457.13-26,669,369.36
(一)基本每股收益0.170.070.01-0.03
(二)稀释每股收益0.160.070.01-0.03
九、综合收益总额317,615,490.92110,774,511.21-16,603,859.15-90,204,109.26
归属于母公司股东的综合收益总额357,959,124.85152,336,082.2416,591,597.98-63,534,739.9
归属于少数股东的综合收益总额-40,343,633.93-41,561,571.03-33,195,457.13-26,669,369.36
公告日期2024-04-192023-10-262023-08-182023-04-25
审计意见(境内)标准无保留意见
TOP↑